Ulobetasol propionate
Ulobetasol propionate, also known as halobetasol propionate, is a synthetic glucocorticoid corticosteroid and a corticosteroid ester.
![]() | |
| Clinical data | |
|---|---|
| Other names | Halobetasol propionate |
| Drug class | Corticosteroid; Glucocorticoid |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| ECHA InfoCard | 100.211.977 |
| Chemical and physical data | |
| Formula | C25H31ClF2O5 |
| Molar mass | 484.96 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
It was patented in 1975 and approved for medical use in 1991.[1]
References
- Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 487. ISBN 9783527607495.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.
